BMY has been in the news 353% more than usual
Oct 02, 2025, 10:31 PM
0.80%
What does BMY do
Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BMY has been in the news recently: Jim Cramer's Charitable Trust sold 300 shares of Bristol Myers Squibb, reducing its ownership to 1,400 shares, while the company's stock is currently trading at $45.73, reflecting a 15.25% decline over the past year. Additionally, Bristol Myers Squibb's stock has decreased by 3.58% today and by 2.06% over the past month.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.